Loading…
Innova Captab (INNOVACAP)₹1,069+0.15%Pharmaceuticals
Innova Captab is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 39.9 against a peer median of 29.4, and ROCE of 15.0% against a peer median of 15.0%, and latest-quarter sales growth of 33.8% against a peer median of 28.1%. By market cap it is #5 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sanofi India | 7,657 | 23.6 | 58.1 | 43.0 | 0.02 | 3.7 | 1,842 | 327 | 7.9 | 19.9 | vs INNOVACAP |
| Bliss GVS Pharma | 6,947 | 43.0 | 17.0 | 11.8 | 0.02 | 0.2 | 925 | 135 | 28.1 | 82.7 | vs INNOVACAP |
| Sun Pharma Advanced Research Company | 6,830 | 4.3 | 164.1 | 278.9 | 0.42 | 0.0 | 1,882 | 1,556 | 299.7 | — | vs INNOVACAP |
| FDC | 6,425 | 20.6 | 15.0 | 11.3 | 0.01 | 1.3 | 2,173 | 282 | 20.8 | 74.8 | vs INNOVACAP |
| Innova Captab | 6,118 | 39.9 | 15.0 | 13.7 | 0.32 | 0.2 | 1,627 | 141 | 33.8 | 42.0 | — |
| IOL Chemicals and Pharmaceuticals | 5,967 | 29.4 | 11.1 | 8.4 | 0.08 | 0.5 | 2,312 | 138 | 40.1 | 116.5 | vs INNOVACAP |
| Morepen Laboratories | 5,433 | 29.2 | 8.0 | 5.3 | 0.17 | 0.2 | 1,808 | 96 | 80.9 | 117.0 | vs INNOVACAP |
| Senores Pharmaceuticals | 5,417 | 40.6 | 15.0 | 13.5 | 0.37 | 0.0 | 632 | 122 | 18.6 | 23.4 | vs INNOVACAP |
| Orchid Pharma | 5,291 | 421.0 | 2.0 | 1.3 | 0.28 | 0.0 | 1,229 | 10 | 15.5 | — | vs INNOVACAP |
| Supriya Lifescience | 5,082 | 24.3 | 25.1 | 19.1 | 0.00 | 0.2 | 826 | 209 | 50.7 | 48.1 | vs INNOVACAP |
| SMS Pharmaceuticals | 4,809 | 46.8 | 13.0 | 14.2 | 0.46 | 0.1 | 886 | 102 | 5.6 | 4.9 | vs INNOVACAP |
| Peer median | 5,967 | 29.4 | 15.0 | 13.5 | 0.17 | 0.2 | 1,627 | 138 | 28.1 | 48.1 |
Listed companies closest to Innova Captab in Pharmaceuticals include Sanofi India, Bliss GVS Pharma, Sun Pharma Advanced Research Company, FDC, IOL Chemicals and Pharmaceuticals, Morepen Laboratories, Senores Pharmaceuticals, Orchid Pharma.
Sanofi India, with a market cap of ₹7,657 Cr.
Innova Captab trades at a P/E of 39.9; the median of its peer set is 29.4. A P/E above or below the median is a description, not a judgement on value.
Innova Captab's return on capital employed is 15.0%, below the peer median of 15.0%.